Literature DB >> 23597700

Evaluation of histological damage of solid organs after donor preconditioning with thymoglobulin in an experimental rat model.

Federico Cicora1, Pablo Stringa, Diego Guerrieri, Daniela Vásquez, Fernanda Toniolo, Javier Roberti, Clemente Raimondi.   

Abstract

Rabbit anti-rat thymoglobulin (rATG) administered to donors with brain death (BD) may improve organs quality. We explored the effects of rATG administered to BD donors in the histology of heart, lungs and small bowel in a rat experimental model. Animals were randomly assigned to 3 groups: V (n=5) no BD, 2h ventilation; BD (n=5) BD and 2h ventilation; BD and rATG: BD, 2h ventilation, rATG (10mg/kg) after BD diagnosis. Histopathological damage scores were based on neutrophil infiltration, airway epithelial cell damage, interstitial edema, hyaline membrane formation, and pulmonary hemorrhage (lungs); neutrophil infiltration and interstitial edema (heart); Park score (bowel). Lung damage was significantly lower in BD+rATG group: V 5 ± 1.6; BD 11.25 ± 0.5, BD+rATG 6.5 ± 1.9 (p<0.01). Heart: V 2.0 ± 0.81; BD 4.75 ± 1.25 and BD+rATG 3.5 ± 1.7 (p>0.05). Small bowel: BD 2.25 ± 0.96 vs. BD+rATG 1.00 ± 1.15 (n.s.). Histological damage amelioration in lung and attenuation tendency in heart and small bowel encourages research of cytoprotective strategies to improve organ viability.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Keywords:  Animal model; Donor preconditioning; Thymoglobulin; Transplantation

Mesh:

Substances:

Year:  2013        PMID: 23597700     DOI: 10.1016/j.trim.2013.04.002

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  1 in total

1.  Oral Preconditioning of Donors After Brain Death With Calcineurin Inhibitors vs. Inhibitors of Mammalian Target for Rapamycin in Pig Kidney Transplantation.

Authors:  Sepehr Abbasi Dezfouli; Mohammadsadegh Nikdad; Omid Ghamarnejad; Elias Khajeh; Alireza Arefidoust; Sara Mohammadi; Ali Majlesara; Mohammadsadegh Sabagh; Negin Gharabaghi; Modar Kentar; Alexander Younsi; Christoph Eckert; Tanja Poth; Mohammad Golriz; Arianeb Mehrabi; Arash Nickkholgh
Journal:  Front Immunol       Date:  2020-06-18       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.